Physician profile
John D Altman
NPI 1780680777
$23,311.03
in general payments reported to CMS, 2019-2025
66 companies · $2,993 in 2025
The $2,993 reported for 2025 was more than what 88% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,766 · 2020: $1,642 · 2021: $2,381 · 2022: $5,345 · 2023: $4,617 · 2024: $3,566 · 2025: $2,993.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Travel and Lodging: $199.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,977.70 |
| Travel and Lodging | $198.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $3,895.52 | 2019-2025 | Impella |
| Boston Scientific Corporation | $2,178.06 | 2019-2025 | Eluvia, Lux-Dx Insertable Cardiac Monitor, Watchman Access System |
| Medtronic, INC. | $2,055.11 | 2021-2025 | Symplicity G3, Onyx Frontier, Micra |
| Amgen INC. | $1,545.25 | 2019-2025 | Repatha, Repatha |
| Shockwave Medical, INC | $1,382.33 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abbott Laboratories | $900.16 | 2019-2025 | Xience Skypoint, Diamondback Peripheral, Viewmate |
| E.R. Squibb & Sons, L.L.C. | $896.11 | 2019-2025 | Eliquis, Camzyos |
| Janssen Pharmaceuticals, INC | $826.63 | 2019-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $791.20 | 2019-2025 | |
| Siemens Medical Solutions USA, INC. | $735.54 | 2019-2023 | Artis Icono Floor |
| Philips North America LLC | $641.62 | 2019-2025 | (6585) Omniwire, (P88) Igt Devices Fm, Ambulatory Monitoring & Diagnostics Undivided |
| Heartflow, INC. | $626.84 | 2022-2025 | |
| Cardiovascular Systems INC. | $516.09 | 2019-2023 | Diamondback Peripheral |
| Boehringer Ingelheim Pharmaceuticals, INC. | $512.37 | 2019-2025 | Jardiance |
| Pfizer INC. | $491.53 | 2019-2025 |
Show all 65 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $429.38 | 2021-2025 | Verquvo |
| Astrazeneca Pharmaceuticals LP | $426.75 | 2019-2025 | Farxiga, Wainua |
| Inari Medical, INC. | $365.48 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Sanofi-Aventis U.S. LLC | $322.26 | 2019-2024 | |
| Impulse Dynamics (USA) INC. | $316.31 | 2022-2024 | Optimizer, Optimizer |
| Edwards Lifesciences Corporation | $312.75 | 2019-2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Alnylam Pharmaceuticals INC. | $231.72 | 2022-2025 | Amvuttra, Onpattro |
| Baxter Healthcare | $224.09 | 2022 | |
| Novo Nordisk INC | $218.96 | 2024-2025 | Ozempic, Rybelsus, Wegovy |
| Kiniksa Pharmaceuticals, LTD. | $218.30 | 2021-2023 | Arcalyst |
| Bard Peripheral Vascular, INC. | $154.60 | 2021-2023 | Lutonix Drug Coated Balloon |
| Cvrx, INC. | $148.72 | 2023 | Barostim Neo System |
| Endologix LLC | $137.73 | 2024 | Torus Stent Graft System, Endocross Device |
| Medtronic Vascular, INC. | $119.97 | 2019-2020 | |
| Esperion Therapeutics, INC. | $109.43 | 2020-2023 | Nexletol |
| W. L. Gore & Associates, INC. | $106.75 | 2019-2024 | Gore Viabahn Vbx Balloon Expandable Endo |
| Scpharmaceuticals INC. | $102.66 | 2023-2025 | |
| Angiodynamics, INC. | $99.63 | 2024 | Auryon Laser System 100-120 Vac |
| Bayer Healthcare Pharmaceuticals INC. | $84.56 | 2019-2021 | |
| Chiesi USA, INC. | $76.43 | 2019-2022 | |
| Amarin Pharma, INC. | $75.99 | 2019-2021 | |
| Otsuka America Pharmaceutical, INC. | $75.77 | 2019 | |
| Bridgebio Pharma, INC. | $68.48 | 2025 | Attruby |
| Kowa Pharmaceuticals America, INC. | $67.82 | 2019-2021 | |
| Bardy Diagnostics, INC. | $67.26 | 2021-2022 | |
| Lexicon Pharmaceuticals, INC. | $64.64 | 2023-2024 | Inpefa |
| Penumbra, INC. | $60.00 | 2024 | Penumbra System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $56.93 | 2019-2023 | Lifevest |
| Regeneron Healthcare Solutions, INC. | $55.94 | 2019 | |
| Microvention, INC. | $52.59 | 2023 | Stent, Web Aneurysm Embolization System |
| Daiichi Sankyo INC. | $42.96 | 2024 | Injectafer |
| Cleerly, INC. | $38.14 | 2024-2025 | Cleerly Labs, Cleerly Ischemia |
| Kestra Medical Technology Services, INC. | $34.71 | 2024 | Assure Wcd |
| Astellas Pharma US INC | $33.42 | 2020 | |
| Inspire Medical Systems, INC. | $31.31 | 2023-2025 | Inspire |
| Veryan Medical Incorporated | $24.65 | 2022 | |
| Ablative Solutions, INC. | $23.19 | 2021 | |
| Gilead Sciences, INC. | $22.79 | 2019 | |
| Teleflex LLC | $22.77 | 2024 | Guideliner |
| Kiniksa Pharmaceuticals International, Plc | $21.97 | 2024 | Arcalyst |
| Stryker Corporation | $21.67 | 2023 | Target |
| Z-Medica, LLC | $20.89 | 2020 | |
| Akcea Therapeutics, INC. | $19.90 | 2021 | |
| Imperative Care, INC | $18.65 | 2025 | Prodigy Catheter |
| Inogen, INC. | $18.02 | 2022 | |
| Cardiva Medical, INC. | $17.26 | 2020 | |
| Atricure, INC. | $14.82 | 2024 | |
| Lilly USA, LLC | $14.69 | 2025 | Zepbound |
| Lantheus Medical Imaging, INC. | $11.76 | 2019 | |
| Ossur Americas, INC. | $11.20 | 2024 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Altman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.